Antibody-targeted chemotherapy of older patients with acute myeloid leukemia in first relapse using Mylotarg (gemtuzumab ozogamicin)
Richard A. Larson(Urbana University), Chatchada Karanes(Erasmus MC Cancer Institute), Philippe Mineur(Centre Hospitalier Universitaire de Lille), Elihu H. Estey(University of Washington), Mihaela Munteanu, MR Loken, FR Appelbaum, EA Stadtmauer(University of Pennsylvania), J M Bennett, M. A. Boogaerts(KU Leuven), ID Bernstein(University of Washington), M. S. Berger(Duke University), Eric L. Sievers(Seagen (United States)), CB Eten
Cited by 224
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k